Low prevalence of insulin-like growth factor-I gene mutations in human growth disorders

J Clin Endocrinol Metab. 1990 Mar;70(3):687-92. doi: 10.1210/jcem-70-3-687.

Abstract

In an attempt to identify genetic lesions contributing to human growth disorders, we evaluated a prospectively recruited group of children with growth failure for mutations in the insulin-like growth factor-I (IGF-I) gene. Two complementary approaches were used: Southern blot analysis to examine the large scale organization of the gene, and a solution hybridization, nuclease protection assay to identify small alterations, such as point mutations. From a total of 61 subjects studied, 52 had no organic basis for their short stature. Analysis of chromosomal DNA from these individuals failed to reveal any variation in the IGF-I gene except for a HindIII site polymorphism which maps near the 3' end of the last IGF-I exon. No single nucleotide substitutions were found within IGF-I-coding regions. Since the frequency of the length polymorphism was the same for both normal-sized and short individuals, it is unlikely to be associated with growth abnormalities. Our results suggest that there is minimal DNA sequence variability in the human IGF-I gene and that mutations in IGF-I exons are infrequent causes of growth failure.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blotting, Southern
  • Child
  • Chromosome Mapping
  • DNA / analysis*
  • DNA Restriction Enzymes
  • Dwarfism, Pituitary / blood
  • Dwarfism, Pituitary / genetics*
  • Exons
  • Female
  • Genes
  • Humans
  • Insulin-Like Growth Factor I / genetics*
  • Male
  • Mutation
  • Oligonucleotide Probes
  • Polymorphism, Genetic
  • RNA, Messenger / analysis*
  • Somatomedins / genetics*

Substances

  • Oligonucleotide Probes
  • RNA, Messenger
  • Somatomedins
  • Insulin-Like Growth Factor I
  • DNA
  • DNA Restriction Enzymes